Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4749110
Max Phase: Preclinical
Molecular Formula: C38H49N9O9S
Molecular Weight: 807.93
Molecule Type: Unknown
Associated Items:
ID: ALA4749110
Max Phase: Preclinical
Molecular Formula: C38H49N9O9S
Molecular Weight: 807.93
Molecule Type: Unknown
Associated Items:
Canonical SMILES: N=C(N)Nc1cc(NC(=O)CCNC(=O)C23CC4CC(CC(C4)C2)C3)cc(C(=O)NCC(=O)NC[C@H](NC(=O)[C@@H]2CCCN2S(=O)(=O)c2ccccc2)C(=O)O)c1
Standard InChI: InChI=1S/C38H49N9O9S/c39-37(40)45-27-15-25(14-26(16-27)44-31(48)8-9-41-36(54)38-17-22-11-23(18-38)13-24(12-22)19-38)33(50)43-21-32(49)42-20-29(35(52)53)46-34(51)30-7-4-10-47(30)57(55,56)28-5-2-1-3-6-28/h1-3,5-6,14-16,22-24,29-30H,4,7-13,17-21H2,(H,41,54)(H,42,49)(H,43,50)(H,44,48)(H,46,51)(H,52,53)(H4,39,40,45)/t22?,23?,24?,29-,30-,38?/m0/s1
Standard InChI Key: SAFQBUKUEAMDGO-GAQHEQIDSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 807.93 | Molecular Weight (Monoisotopic): 807.3374 | AlogP: 0.92 | #Rotatable Bonds: 16 |
Polar Surface Area: 282.08 | Molecular Species: ZWITTERION | HBA: 9 | HBD: 9 |
#RO5 Violations: 2 | HBA (Lipinski): 18 | HBD (Lipinski): 10 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 3.03 | CX Basic pKa: 9.03 | CX LogP: -1.70 | CX LogD: -1.71 |
Aromatic Rings: 2 | Heavy Atoms: 57 | QED Weighted: 0.08 | Np Likeness Score: -1.23 |
1. Sundaram A,Chen C,Isik Reed N,Liu S,Ki Yeon S,McIntosh J,Tang YZ,Yang H,Adler M,Beresis R,Seiple IB,Sheppard D,DeGrado WF,Jo H. (2020) Dual antagonists of α5β1/αvβ1 integrin for airway hyperresponsiveness., 30 (22): [PMID:33007395] [10.1016/j.bmcl.2020.127578] |
Source(1):